{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:12Z","timestamp":1794047472159,"version":"4.8.0"},"reference-count":51,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"11","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Impaired differentiation of megakaryocytes constitutes the principal etiology of thrombocytopenia. The signal transducer and activator of transcription 3 (STAT3) is a crucial transcription factor in regulating megakaryocyte differentiation, however the precise mechanism of its activation remains unclear. PALLD, an actin-associated protein, has been increasingly recognized for its essential functions in multiple biological processes. This study revealed that megakaryocyte\/platelet-specific knockout of Palld in mice exhibited thrombocytopenia due to diminished platelet biogenesis. In megakaryocytes, PALLD deficiency led to impaired proplatelet formation and polyploidization, ultimately weakening their differentiation for platelet production. Mechanistic studies demonstrated that PALLD bound to STAT3 and interacted with its DNA-binding domain and Src homology 2 domain via immunoglobulin domain 3. Moreover, the absence of PALLD attenuated STAT3 Y705 phosphorylation and impeded STAT3 nuclear translocation. Based on the PALLD-STAT3 binding sequence, we designed a peptide C-P3, which can facilitate megakaryocyte differentiation and accelerate platelet production in vivo. In conclusion, this study highlights the pivotal role of PALLD in megakaryocyte differentiation and proposes a novel approach for treating thrombocytopenia by targeting the PALLD-STAT3 interaction.<\/jats:p>","DOI":"10.3324\/haematol.2024.285242","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T08:24:31Z","timestamp":1717057471000},"page":"3693-3704","source":"Crossref","is-referenced-by-count":0,"title":["The role of PALLD-STAT3 interaction in megakaryocyte differentiation and thrombocytopenia treatment"],"prefix":"10.3324","volume":"109","author":[{"given":"Guoming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"68690","doi-asserted-by":"crossref","unstructured":"Stanworth SJ, Shah A. How I use platelet transfusions. Blood. 2022; 140(18):1925-1936.","DOI":"10.1182\/blood.2022016558"},{"key":"68691","doi-asserted-by":"crossref","unstructured":"Corash L, Chen HY, Levin J. Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood. 1987; 70(1):177-185.","DOI":"10.1182\/blood.V70.1.177.bloodjournal701177"},{"key":"68692","doi-asserted-by":"crossref","unstructured":"Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients?. Br J Haematol. 2017; 177(1):27-38.","DOI":"10.1111\/bjh.14482"},{"key":"68693","doi-asserted-by":"crossref","unstructured":"Machlus KR, Italiano JE Jr. The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol. 2013; 201(6):785-796.","DOI":"10.1083\/jcb.201304054"},{"key":"68694","doi-asserted-by":"crossref","unstructured":"Noetzli LJ, French SL, Machlus KR. New insights into the differentiation of megakaryocytes from hematopoietic progenitors. Arterioscler Thromb Vasc Biol. 2019; 39(7):1288-1300.","DOI":"10.1161\/ATVBAHA.119.312129"},{"key":"68695","doi-asserted-by":"crossref","unstructured":"Tilburg J, Becker IC, Italiano JE. Don\u2019t you forget about me(gakaryocytes). Blood. 2022; 139(22):3245-3254.","DOI":"10.1182\/blood.2020009302"},{"key":"68696","doi-asserted-by":"crossref","unstructured":"Bluteau D, Lordier L, Di Stefano A. Regulation of megakaryocyte maturation and platelet formation. J Thromb Haemost. 2009; 7(Suppl 1):227-234.","DOI":"10.1111\/j.1538-7836.2009.03398.x"},{"key":"68697","doi-asserted-by":"crossref","unstructured":"Kaushansky K, Lok S, Holly RD. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369(6481):568-571.","DOI":"10.1038\/369568a0"},{"key":"68698","doi-asserted-by":"crossref","unstructured":"Drachman JG, Sabath DF, Fox NE, Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood. 1997; 89(2):483-492.","DOI":"10.1182\/blood.V89.2.483"},{"key":"68699","doi-asserted-by":"crossref","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/ STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018; 15(4):234-248.","DOI":"10.1038\/nrclinonc.2018.8"},{"key":"68700","doi-asserted-by":"crossref","unstructured":"Kuter DJ. New thrombopoietic growth factors. Blood. 2007; 109(11):4607-4616.","DOI":"10.1182\/blood-2006-10-019315"},{"key":"68701","doi-asserted-by":"crossref","unstructured":"Gurney AL, Wong SC, Henzel WJ, de Sauvage FJ. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci U S A. 1995; 92(12):5292-5296.","DOI":"10.1073\/pnas.92.12.5292"},{"key":"68702","doi-asserted-by":"crossref","unstructured":"Sun L, Yan Y, Lv H. Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth. Cell Chem Biol. 2022; 29(3):373-385.","DOI":"10.1016\/j.chembiol.2021.10.006"},{"key":"68703","doi-asserted-by":"crossref","unstructured":"Tripathi SK, Chen Z, Larjo A. Genome-wide analysis of STAT3-mediated transcription during early human Th17 cell differentiation. Cell Rep. 2017; 19(9):1888-1901.","DOI":"10.1016\/j.celrep.2017.05.013"},{"key":"68704","doi-asserted-by":"crossref","unstructured":"Goicoechea SM, Arneman D, Otey CA. The role of palladin in actin organization and cell motility. Eur J Cell Biol. 2008; 87(8-9):517-525.","DOI":"10.1016\/j.ejcb.2008.01.010"},{"key":"68705","doi-asserted-by":"crossref","unstructured":"Parast MM, Otey CA. Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J Cell Biol. 2000; 150(3):643-656.","DOI":"10.1083\/jcb.150.3.643"},{"key":"68706","doi-asserted-by":"crossref","unstructured":"Mykk\u00e4nen OM, Gr\u00f6nholm M, R\u00f6nty M. Characterization of human palladin, a microfilament-associated protein. Mol Biol Cell. 2001; 12(10):3060-3073.","DOI":"10.1091\/mbc.12.10.3060"},{"key":"68707","doi-asserted-by":"crossref","unstructured":"Jin L, Gan Q, Zieba BJ. The actin associated protein palladin is important for the early smooth muscle cell differentiation. PLoS One. 2010; 5(9):e12823.","DOI":"10.1371\/journal.pone.0012823"},{"key":"68708","doi-asserted-by":"crossref","unstructured":"Shu X, Chen M, Liu SY. Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt\/B-Catenin signaling. Cancer Med. 2023; 12(4):4510-4520.","DOI":"10.1002\/cam4.5192"},{"key":"68709","doi-asserted-by":"crossref","unstructured":"Chen X, Fan X, Tan J. Palladin is involved in platelet activation and arterial thrombosis. Thromb Res. 2017; 149:1-8.","DOI":"10.1016\/j.thromres.2016.11.010"},{"key":"68710","doi-asserted-by":"crossref","unstructured":"Xu Y, Ouyang X, Yan L. Sin1 (stress-activated protein kinase-interacting protein) regulates ischemia-induced microthrombosis through integrin aIIbp3-mediated outside-in signaling and hypoxia responses in platelets. Arterioscler Thromb Vasc Biol. 2018; 38(12):2793-2805.","DOI":"10.1161\/ATVBAHA.118.311822"},{"key":"68711","doi-asserted-by":"crossref","unstructured":"Jiang H, Yu Z, Ding N. The role of AGK in thrombocytopoiesis and possible therapeutic strategies. Blood. 2020; 136(1):119-129.","DOI":"10.1182\/blood.2019003851"},{"key":"68712","doi-asserted-by":"crossref","unstructured":"Tiedt R, Schomber T, Hao-Shen H, Skoda RC. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood. 2007; 109(4):1503-1506.","DOI":"10.1182\/blood-2006-04-020362"},{"key":"68713","doi-asserted-by":"crossref","unstructured":"Skarnes WC, Rosen B, West AP. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011; 474(7351):337-342.","DOI":"10.1038\/nature10163"},{"key":"68714","doi-asserted-by":"crossref","unstructured":"Kaushansky K. Thrombopoiesis. Semin Hematol. 2015; 52(1):4-11.","DOI":"10.1053\/j.seminhematol.2014.10.003"},{"key":"68715","doi-asserted-by":"crossref","unstructured":"Pang L, Xue HH, Szalai G. Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins. Blood. 2006; 108(7):2198-2206.","DOI":"10.1182\/blood-2006-04-019760"},{"key":"68716","doi-asserted-by":"crossref","unstructured":"Vijey P, Posorske B, Machlus KR. In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells. Platelets. 2018; 29(6):583-588.","DOI":"10.1080\/09537104.2018.1492107"},{"key":"68717","doi-asserted-by":"crossref","unstructured":"Bush LM, Healy CP, Marvin JE, Deans TL. High-throughput enrichment and isolation of megakaryocyte progenitor cells from the mouse bone marrow. Sci Rep. 2021; 11(1):8268.","DOI":"10.1038\/s41598-021-87681-2"},{"key":"68718","doi-asserted-by":"crossref","unstructured":"Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest. 2005; 115(12):3348-3354.","DOI":"10.1172\/JCI26891"},{"key":"68719","doi-asserted-by":"crossref","unstructured":"Yamamoto R, Morita Y, Ooehara J. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell. 2013; 154(5):1112-1126.","DOI":"10.1016\/j.cell.2013.08.007"},{"key":"68720","doi-asserted-by":"crossref","unstructured":"Plo I, Bellann\u00e9-Chantelot C, Mosca M. Genetic alterations of the thrombopoietin\/MPL\/JAK2 axis impacting megakaryopoiesis. Front Endocrinol (Lausanne). 2017; 8:234.","DOI":"10.3389\/fendo.2017.00234"},{"key":"68721","doi-asserted-by":"crossref","unstructured":"Rachlin AS, Otey CA. Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin. J Cell Sci. 2006; 119(Pt 6):995-1004.","DOI":"10.1242\/jcs.02825"},{"key":"68722","doi-asserted-by":"crossref","unstructured":"Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA. Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J. 2012; 443(3):851-856.","DOI":"10.1042\/BJ20120150"},{"key":"68723","doi-asserted-by":"crossref","unstructured":"Fung HY, Chook YM. Atomic basis of CRM1-cargo recognition, release and inhibition. Semin Cancer Biol. 2014; 27:52-61.","DOI":"10.1016\/j.semcancer.2014.03.002"},{"key":"68724","doi-asserted-by":"crossref","unstructured":"Jans DA, Martin AJ, Wagstaff KM. Inhibitors of nuclear transport. Curr Opin Cell Biol. 2019; 58:50-60.","DOI":"10.1016\/j.ceb.2019.01.001"},{"key":"68725","doi-asserted-by":"crossref","unstructured":"Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear location. Cell. 1984; 39(3 Pt 2):499-509.","DOI":"10.1016\/0092-8674(84)90457-4"},{"key":"68726","doi-asserted-by":"crossref","unstructured":"Lu J, Wu T, Zhang B. Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun Signal. 2021; 19(1):60.","DOI":"10.1186\/s12964-021-00741-y"},{"key":"68727","doi-asserted-by":"crossref","unstructured":"Copolovici DM, Langel K, Eriste E, Langel \u00dc. Cell-penetrating peptides: design, synthesis, and applications. ACS Nano. 2014; 8(3):1972-1994.","DOI":"10.1021\/nn4057269"},{"key":"68728","doi-asserted-by":"crossref","unstructured":"Albraiki S, Ajiboye O, Sargent R, Beck MR. Functional comparison of full-length palladin to isolated actin binding domain. Protein Sci. 2023; 32(5):e4638.","DOI":"10.1002\/pro.4638"},{"key":"68729","doi-asserted-by":"crossref","unstructured":"Gilam A, Conde J, Weissglas-Volkov D. Local microRNA delivery targets Palladin and prevents metastatic breast cancer. Nat Commun. 2016; 7:12868.","DOI":"10.1038\/ncomms12868"},{"key":"68730","doi-asserted-by":"crossref","unstructured":"Chin YR, Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol Cell. 2010; 38(3):333-344.","DOI":"10.1016\/j.molcel.2010.02.031"},{"key":"68731","doi-asserted-by":"crossref","unstructured":"Wang W, Goswami S, Lapidus K. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 2004; 64(23):8585-8594.","DOI":"10.1158\/0008-5472.CAN-04-1136"},{"key":"68732","doi-asserted-by":"crossref","unstructured":"Liu H, Zhang Y, Li L. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?. Mol Ther Oncolytics. 2021; 20:240-264.","DOI":"10.1016\/j.omto.2020.12.014"},{"key":"68733","doi-asserted-by":"crossref","unstructured":"Mazzi S, Dessen P, Vieira M. Dual role of EZH2 in megakaryocyte differentiation. Blood. 2021; 138(17):1603-1614.","DOI":"10.1182\/blood.2019004638"},{"key":"68734","doi-asserted-by":"crossref","unstructured":"Hillmer EJ, Zhang H, Li HS, Watowich SS. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 2016; 31:1-15.","DOI":"10.1016\/j.cytogfr.2016.05.001"},{"key":"68735","doi-asserted-by":"crossref","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9(11):798-809.","DOI":"10.1038\/nrc2734"},{"key":"68736","doi-asserted-by":"crossref","unstructured":"Zou S, Tong Q, Liu B. Targeting STAT3 in cancer immunotherapy. Mol Cancer. 2020; 19(1):145.","DOI":"10.1186\/s12943-020-01258-7"},{"key":"68737","doi-asserted-by":"crossref","unstructured":"Kraskouskaya D, Duodu E, Arpin CC, Gunning PT. Progress towards the development of SH2 domain inhibitors. Chem Soc Rev. 2013; 42(8):3337-3370.","DOI":"10.1039\/c3cs35449k"},{"key":"68738","doi-asserted-by":"crossref","unstructured":"Furtek SL, Backos DS, Matheson CJ, Reigan P. Strategies and approaches of targeting STAT3 for cancer treatment. ACS Chem Biol. 2016; 11(2):308-318.","DOI":"10.1021\/acschembio.5b00945"},{"key":"68739","doi-asserted-by":"crossref","unstructured":"Beebe JD, Liu JY, Zhang JT. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?. Pharmacol Ther. 2018; 191:74-91.","DOI":"10.1016\/j.pharmthera.2018.06.006"},{"key":"68740","doi-asserted-by":"crossref","unstructured":"Wong ALA, Hirpara JL, Pervaiz S. Do STAT3 inhibitors have potential in the future for cancer therapy?. Expert Opin Investig Drugs. 2017; 26(8):883-887.","DOI":"10.1080\/13543784.2017.1351941"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285242\/77108","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285242\/77712","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11629\/77108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:30Z","timestamp":1794045990000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285242","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}